FDA Investigator Shalonda C Clifford

Shalonda C Clifford has conducted inspections on 49 sites in 3 countries as of 20 Feb 2020. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
49
Last Inspection Date:
20 Feb 2020
Investigator Role:
FDA Investigator
Redica ID:
100006726
Countries of Inspections:
United States of America, Canada, Peru
FDA Investigators that have inspected at least one site in common with Shalonda C Clifford:
Adam J Taylor, Alan M Barker, Alecia L Marson, Amanda E Lewin, PhD, Ana E Morales, Andrace L Deyampert, Andrew A Hoopes, April L Young, Brian D Nicholson, Bruce H Mccullough, Carl J Montgomery, Carolyn A Warren, Cheryl A Grandinetti, Christina A Miller, Claudette D Brooks, Colleen E Burke, Connie L Richard, Constance L Richard, Corey K Reno, Courtney R Tiegs, Debra I Love, Debra Lboyd Seale, Denise L Burosh, Diane T Reindl, Dr. Jason R Caballero, Dr. Zhou Chen (nmi), MD PhD, Edward E Lockwood (EEL), Emily S Mcgann, Eric A Breselow, Gamal A Norton, Gerald E Scholze, Gordon T Wales, Gregory W Smith, Howard A Burmester, Ivan E Reyes, Jacob W Reynolds, James P Duggan, James W Plucinski, Janis R Armedoriz, Jasjeet K Sekhon, Jeanne J Chiu, Jeanne J Thai, Jeffry A Bernhardt, Jennifer C Adams, Jennifer C Johnson, Jennifer Guttuso, Jesse A Vazquez, Jesse P Romenesko, Jessica L Barr, Jessica L Johnson, Joel D Hustedt, John Misock, Joseph A Piechocki, Justin A Boyd, Kara A Scheibner, PhD, Karen Emasley Joseph, Karen M Montgomery (KMM), Katherine A Clarke Girolamo, Kathleen S Tormey, Kathryn M Mogen, Keith C Rindahl, Kia L Copeland, Kimberly Lewandowski Walker, Kristy E Zuroski, Lauren A Crivellone, Lauren N Howard, Lequita M Mayhew, Liliya V Bubiy, Linda V Weyer, Lisa Hayka, Lisa M Lopez, Marcia A Worley, Margaret Torres Vazquez, Marie A Fadden, Melissa I Michurski, Melissa J Holz, Michele L Glendenning, Michele Perry Williams, Michelle J Glembin, Nicholas P Diorio, Nicholas Z Lu, Nicole C Shokatz, Nicole S Williams, Rafael Padilla, Richard Jay Tucker, RS, Richard M Willey, Robert J Ham, Russell K Riley, Sandra A Hughes, Sandra D Wilson, Sarah A Palmer, Sharon K Thoma, PharmD, Sherri J Jackson, Soyinka S Eneng, Sullan, Susan D Yuscius, Suzanne M Crotty, Tamara M Qtami, Tamara Qtami, Tara M Humfeld, Tenzin Jangchup, Uruaku A Obasi, Wendy A Good, William D Sherman, Yiyue Zhang (nmi), PhD, Yuanyuan Li

Shalonda C Clifford's Documents

Publish Date Document Type Title
July, 2016 FDA 483 Chemrite Copac, Inc. - Form 483, 2016-07-15
March, 2016 FDA 483 Chemrite Copac, Inc. - Form 483, 2016-03-24
February, 2020 FDA 483 William J. Gradishar, M.D. - Form 483, 2020-02-28
April, 2018 FDA 483 Asthma and Allergy Center of Chicago SC - Form 483, 2018-04-23
August, 2019 FDA 483 Kenneth Choi, M.D. - Form 483, 2019-08-30
October, 2015 FDA 483 Nancy Sweitzer - Form 483, 2015-10-30
April, 2019 EIR AVADEL LEGACY PHARMACEUTICALS, LLC - EIR, 2019-04-24
September, 2015 FDA 483 Uriel Pharmacy - Form 483, 2015-09-03
January, 2017 FDA 483 Grace Analytical Laboratory, Inc - Form 483, 2017-01-30
March, 2018 FDA 483 Charles River Laboratories, Inc- IL - Form 483, 2018-03-08
February, 2020 FDA 483 Copley Memorial Hospital - Form 483, 2020-02-10
April, 2019 EIR Azazuddin A. Ahmed, MD - EIR, 2019-04-30
July, 2016 FDA 483 Response Chemrite Copac, Inc. - Form 483R, 2016-08-04
September, 2018 EIR Charles River Laboratories Ashland, LLC - EIR, 2018-09-14
April, 2019 FDA 483 Azazuddin A. Ahmed, MD - Form 483, 2019-04-30
October, 2015 EIR Nancy Sweitzer - EIR, 2015-09-30
October, 2015 FDA 483 Response Nancy Sweitzer - Form 483R, 2015-10-16
October, 2019 FDA 483 Richard Bernstein, MD, PhD - Form 483, 2019-10-10
November, 2018 EIR AbbVie Inc. - EIR, 2019-01-25
October, 2015 FDA 483 Rockline Industries - Form 483, 2015-10-06
March, 2019 FDA 483 Sufit, Robert, M.D. - Form 483, 2019-03-04
October, 2015 EIR Rockline Industries - EIR, 2015-10-06
November, 2015 FDA 483 Bell Pharmaceuticals, Inc. - Form 483, 2015-11-20
June, 2019 FDA 483 MercyOne North Iowa Medical Center IRB - Form 483, 2019-06-21

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more